Pharmacists to be key players in pharmacogenomics?

By  

Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Pharmacogenomics

By  

Current Drug Metabolism, Vol. 9, Iss. 3, 2008-03 ,pp. : 207-212

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of &bgr;β₂-agonist: key focus on signaling pathways

By Bhatnagar Pallav   Guleria Randeep   Kukreti Ritushree  

Pharmacogenomics, Vol. 7, Iss. 6, 2006-09 ,pp. : 919-933

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Antidepressant Drugs: Focus on Key Findings and Future Directions

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 3, 2015-03 ,pp. : 141-147

Bentham Science Publishers

Access to resources Recommend Favorite

Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 1, 2011-03 ,pp. : 41-66

Bentham Science Publishers

Access to resources Recommend Favorite